MolecuLight Inc.: MolecuLight Featured in Unprecedented 24 P

Wide-Spread Clinical Evidence using the MolecuLight Imaging Platform Reveals its Significant Global Adoption and Proven Utility in Wound Care TORONTO and MILAN, May 3, 2023 /PRNewswire/

Related Keywords

Italy , Ireland , Milan , Lombardia , United States , Canada , Dublin , Israel , Toronto , Ontario , Jerusalem , Israel General , Laura Jones , Aharon Wanszelbaum , Carlotta Scarpa , Nicola Riitano , Thomas Serena , Alessandra Michelucci , Rosemarie Derwin , Charles Andersen , Rob Sandler , Moleculight Inc , Surgical Center , Hospital Outpatient Department , Valentina Dini University Of Pisa , Prnewswire Moleculight Inc , Serena Group , Health Canada , European Wound Management Association , Wide Spread Clinical Evidence , Moleculight Imaging Platform Reveals , Significant Global Adoption , Proven Utility , Light Inc , Anil Amlani , Medical Director , Select Clinicalposters , Select Clinical Presentations , Valentina Dini , Room Amber , Diabetic Foot , Joint Base Lewis Mcchord , Wound Assessment , Ambulatory Surgical Center , Ambulatory Payment Classification , Chief Marketing Officer , Moleculight , Featured , Unprecedented , Presentations , Posters , European , Hound , Management , Association , Cwma , 023 , Nnual , Conference ,